Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis

Current drug development efforts on gastric cancer are directed against several molecular targets driving the growth of this neoplasm. Intra-tumoral biomarker heterogeneity however, commonly observed in gastric cancer, could lead to biased selection of patients. MET, ATM, FGFR2, and HER2 were profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Peng, Zhang, Meizhuo, Fan, Shuqiong, Zhang, Tianwei, Fu, Haihua, Su, Xinying, Gavine, Paul R., Liu, Qiang, Yin, Xiaolu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654477/
https://www.ncbi.nlm.nih.gov/pubmed/26587992
http://dx.doi.org/10.1371/journal.pone.0143207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654477/
https://www.ncbi.nlm.nih.gov/pubmed/26587992
http://dx.doi.org/10.1371/journal.pone.0143207

Ejemplares similares